Abstract
Excessive scarring (fibrosis) is a major cause of pathologies in multiple tissues, including lung, liver, kidney, heart, cornea, and skin. The transforming growth factor-β (TGF-β) system has been shown to play a key role in regulating the formation of scar tissue throughout the body. Furthermore, connective tissue growth factor (CTGF) has been shown to mediate most of the fibrotic actions of TGF-β, including stimulation of synthesis of extracellular matrix and differentiation of fibroblasts into myofibroblasts. Currently, no approved drugs selectively and specifically regulate scar formation. Thus, there is a need for a drug that selectively targets the TGF-β cascade at the molecular level and has minimal off-target side effects. This chapter focuses on the design of hammerhead ribozymes, measurement of kinetic activity, and assessment of knockdown mRNAs of TGF-β and CTGF in cell cultures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Border, W.A., Noble, N.A., Yamamoto, T., Harper, J.R., Yamaguchi, Y., Pierschbacher, M.D. Ruoslahti, E. (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361–364.
Border, W. A., Noble, N. A. (1994) Transforming Growth Factor B in Tissue Fibrosis. N. Engl. J. Med. 331: 1286–1292.
Grotendorst, G.R., Duncan, M.R. (2005) Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J. 19: 729–738.
Lewin, A., Hauswirth, W. (2007) Ribozyme gene therapy: applications for molecular medicine. Trends Mol. Med. 7: 221–228.
Lee, P.A., Blatt, L.M., Blanchard, K.S., Bouhana, K.S., Pavco, P.A., Bellon, L., Sandberg, J.A. (2000) Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice. Hepatology 32: 640–646.
Shimayama, T., Nishikawa, S., Taira, K. (1995) Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes. Biochemistry 34: 3649–3654.
Fritz, J.J., Lewin, A., Hauswirth, W., Agarwal, A., Grant, M., Shaw, L. (2002) Development of hammerhead ribozymes to modulate endogenous gene expression for functional studies. Methods 28: 276–285.
Drenser, K.A., Timmers, A.M., Hauswirth, W.W., Lewin, A.S. (1998) Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 39: 681–689.
Heid, C.A., Stevens, J., Livak, K.J., Williams, D.M. (1996) Real time quantitative PCR. Genome Res. 10: 984–986.
Blalock, T.D., Duncan, M.R., Varela, J.C., Goldstein, M.H., Tuli, S.S., Grotendorst, G.R., Schultz, G.S. (2003) Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 44: 1879–1887.
Tamatani, T., Kobayashi, H., Tezuka, K., Sakamoto, S., Suzuki, K., Nakanishi, T., Takigawa, M., Miyano, T. (1998) Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem. Biophys. Res. Commun. 251: 748–752.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Robinson, P.M., Blalock, T.D., Yuan, R., Lewin, A.S., Schultz, G.S. (2012). Hammerhead Ribozyme-Mediated Knockdown of mRNA for Fibrotic Growth Factors: Transforming Growth Factor-Beta 1 and Connective Tissue Growth Factor. In: De Ley, M. (eds) Cytokine Protocols. Methods in Molecular Biology, vol 820. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-439-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-61779-439-1_8
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-438-4
Online ISBN: 978-1-61779-439-1
eBook Packages: Springer Protocols